These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

787 related items for PubMed ID: 17307447

  • 1. Outcomes associated with the use of secondary prevention medications after coronary artery bypass graft surgery.
    Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson TB, Peterson ED, PREVENT IV Investigators.
    Ann Thorac Surg; 2007 Mar; 83(3):993-1001. PubMed ID: 17307447
    [Abstract] [Full Text] [Related]

  • 2. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study.
    Bi Y, Gao R, Patel A, Su S, Gao W, Hu D, Huang D, Kong L, Qi W, Wu Y, Yang Y, Turnbull F, CPACS Investigators.
    Am Heart J; 2009 Mar; 157(3):509-516.e1. PubMed ID: 19249422
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Factors associated with the use of evidence-based therapies after discharge among elderly patients with myocardial infarction.
    Austin PC, Tu JV, Ko DT, Alter DA.
    CMAJ; 2008 Oct 21; 179(9):901-8. PubMed ID: 18936455
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Use of secondary preventive medications after the first attack of acute coronary syndrome.
    Salomaa V, Pääkkönen R, Hämäläinen H, Niemi M, Klaukka T.
    Eur J Cardiovasc Prev Rehabil; 2007 Jun 21; 14(3):386-91. PubMed ID: 17568237
    [Abstract] [Full Text] [Related]

  • 12. Use of perioperative cardiac medical therapy among patients undergoing coronary artery bypass graft surgery.
    Filion KB, Pilote L, Rahme E, Eisenberg MJ.
    J Card Surg; 2008 Jun 21; 23(3):209-15. PubMed ID: 18435634
    [Abstract] [Full Text] [Related]

  • 13. Under-use of secondary prevention medication in acute coronary syndrome patients treated with in-hospital coronary artery bypass graft surgery.
    Looi KL, Chow KL, Looi JL, Lee M, Halliday S, White H, Ellis C.
    N Z Med J; 2011 Sep 23; 124(1343):18-27. PubMed ID: 21964009
    [Abstract] [Full Text] [Related]

  • 14. Preoperative angiotensin-converting enzyme inhibitors protect myocardium from ischemia during coronary artery bypass graft surgery.
    Benedetto U, Melina G, Capuano F, Comito C, Bianchini R, Simon C, Refice S, Angeloni E, Sinatra R.
    J Cardiovasc Med (Hagerstown); 2008 Nov 23; 9(11):1098-103. PubMed ID: 18852580
    [Abstract] [Full Text] [Related]

  • 15. Influence of preoperative renal dysfunction on one-year bypass graft patency and two-year outcomes in patients undergoing coronary artery bypass surgery.
    Mehta RH, Hafley GE, Gibson CM, Harrington RA, Peterson ED, Mack MJ, Kouchoukos NT, Califf RM, Ferguson TB, Alexander JH, Project of Ex-vivo Vein Graft Engineering via Transfection (PREVENT)-IV Investigators.
    J Thorac Cardiovasc Surg; 2008 Nov 23; 136(5):1149-55. PubMed ID: 19026795
    [Abstract] [Full Text] [Related]

  • 16. Should all patients be treated with an angiotensin-converting enzyme inhibitor after coronary artery bypass graft surgery? The impact of angiotensin-converting enzyme inhibitors, statins, and β-blockers after coronary artery bypass graft surgery.
    Kalavrouziotis D, Buth KJ, Cox JL, Baskett RJ.
    Am Heart J; 2011 Nov 23; 162(5):836-43. PubMed ID: 22093199
    [Abstract] [Full Text] [Related]

  • 17. Recent trends in the care of patients with non-ST-segment elevation acute coronary syndromes: insights from the CRUSADE initiative.
    Mehta RH, Roe MT, Chen AY, Lytle BL, Pollack CV, Brindis RG, Smith SC, Harrington RA, Fintel D, Fraulo ES, Califf RM, Gibler WB, Ohman EM, Peterson ED.
    Arch Intern Med; 2006 Oct 09; 166(18):2027-34. PubMed ID: 17030838
    [Abstract] [Full Text] [Related]

  • 18. Impact of combined secondary prevention therapy after myocardial infarction: data from a nationwide French registry.
    Danchin N, Cambou JP, Hanania G, Kadri Z, Genès N, Lablanche JM, Blanchard D, Vaur L, Clerson P, Guéret P, USIC 2000 investigators.
    Am Heart J; 2005 Dec 09; 150(6):1147-53. PubMed ID: 16338251
    [Abstract] [Full Text] [Related]

  • 19. Renin-angiotensin system and haemostasis gene polymorphisms and outcome after coronary artery bypass graft surgery.
    Völzke H, Kleine V, Robinson DM, Grimm R, Hertwig S, Schwahn C, Eckel L, Rettig R.
    Int J Cardiol; 2005 Jan 09; 98(1):133-9. PubMed ID: 15676177
    [Abstract] [Full Text] [Related]

  • 20. Effect of beta-blocker therapy on mortality rates and future myocardial infarction rates in patients with coronary artery disease but no history of myocardial infarction or congestive heart failure.
    Bunch TJ, Muhlestein JB, Bair TL, Renlund DG, Lappé DL, Jensen KR, Horne BD, Carter MA, Anderson JL, Intermountain Heart Collaborative Study Group.
    Am J Cardiol; 2005 Apr 01; 95(7):827-31. PubMed ID: 15781009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.